CDT
No price yet
Announcements
Nothing here yet
Daily updates
- CDT Affiliate Sarborg Files Patent Application for Respiratory Candidate Targeting a $20 Billion-Plus MarketOct 15, 2026
- CDT Equity Portfolio Company Sarborg Files Patent Application for Novel Respiratory Candidate Solid FormsOct 14, 2026
- Conduit collaborated with QIMA Life Sciences to evaluate tapinarof combination therapies for autoimmune skin conditions using human skin models from healthy individuals and affected patients, with a focus on psoriasis and vitiligo.Sep 18, 2026
FDA designations
Nothing here yet
News
- CDT partnered with QIMA Life Sciences to evaluate novel tapinarof combinations for psoriasis and vitiligoSep 18, 2026
- CDT invested in Pep'd to expand its presence in the rapidly growing U.S. peptide marketAug 25, 2026
- CDT advanced AZD5904 into the global patent phase and initiated partnering discussionsMay 6, 2026
- CDT Equity expanded its tapinarof IP portfolio with two new patent filingsMar 26, 2026
- Conduit Pharmaceuticals receives further patent approval for its lead asset targeting autoimmune diseases.May 9, 2025